Skip to content

investigation the effect of Irreversible electroporation for advanced pancreatic cancer

investigation the effect of Irreversible electroporation for advanced pancreatic cancer

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230403057807N2
Enrollment
5
Registered
2025-07-07
Start date
2025-08-06
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer. Malignant neoplasm of pancreas

Interventions

Intervention 1: Intervention Group 1: Patients in this group, who have pancreatic cancer, receive irreversible electroporation during their surgical procedure. After the tumor is removed, electrical p

Sponsors

Bagheiat-allah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patient has a tumor in the pancreas. The patient has a history of chemotherapy. The person should not have metal chips, platinum, or other metals within the treatment area. 2 Specialists should consider this type of treatment permissible for the patient.

Exclusion criteria

Exclusion criteria: The person has metal chips, platinum, and other metals within the treatment area.

Design outcomes

Primary

MeasureTime frame
Determining and comparing the effect of irreversible electroporation on reducing pancreatic tumor volume based on treatment groups. Timepoint: Before and after treatment, one month. Method of measurement: MRI and CT images before and after treatment.;Determining and comparing the effect of irreversible electroporation on the survival of patients with pancreatic tumors based on treatment groups. Timepoint: Before and after treatment, one month. Method of measurement: Clinical examination and use of the Omid Miller checklist.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZeinab Shankayi

Bagheiat-allah University of Medical Sciences

z.shankayi@gmail.com+98 21 6689 2058

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026